serena williams which glp 1 shares her journey using GLP-1 treatments to lose weight Serena Williams Touts GLP-1 Health

Semaglutide (Wegovy) has been granted FDA approval for the treatment of metabolic-associated steatohepatitis (MASH, or NASH with fibrosis)

The company could further leverage its existing behavior change framework and technology to develop programs for conditions like hypertension, high cholesterol, and heart disease - all of which have strong links to obesity and lifestyle factors

Any kind of rapid weight loss the aftermath of giving birth, say, or a serious illness puts the body through physiological stress

It gives a black eye to telemedicine, said Elizabeth Krupinski, an experimental psychologist at Emory University who has conducted research on the effectiveness of telehealth